Logotype for Nanoform Finland

Nanoform Finland (NANOFH) investor relations material

Nanoform Finland CMD 2025 Presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Nanoform Finland
CMD 2025 Presentation summary16 Dec, 2025

Strategic vision and business targets for 2026–2030

  • Aims to break technological barriers in both small and large molecule drug development using CESS® for small molecules and BioLine for biologics, supporting the industry shift from IV to subcutaneous delivery.

  • Targets over 300 non-GMP projects and more than 30 GMP projects by 2030, with three nanoformed medicines launched by that year.

  • Sets ambitious financial goals: revenue exceeding €30 million, cumulative milestones over €30 million, and income growth above 50% CAGR from 2026–2030, with EBIT margin above 30%.

  • Cost growth is projected to remain below 5% CAGR due to prior investments in manufacturing scale-up and digital infrastructure.

Industry context and technology differentiation

  • Despite rising global pharma R&D spending, the number of new FDA drug approvals has remained flat, highlighting the need for innovative solutions.

  • Nanoform’s technology addresses low transition rates from preclinical to GMP projects, aiming to reach industry standards by 2030.

  • The CESS® process enables efficient, scalable nanoforming, with significant improvements in throughput and cost since 2021.

  • BioLine technology produces highly stable, high-concentration biologic suspensions, validated by large pharma partners for injectable and pulmonary delivery.

Product pipeline and partnerships

  • Pipeline includes nanoenzalutamide (prostate cancer), nanoapalutamide, nanoencorafenib (melanoma/colorectal cancer), and GLIORA (glioma), with launches targeted between 2028–2033.

  • Strategic partnerships with Helm Pharmaceuticals, Brafmed, and Revio Therapeutics support product development, regulatory submissions, and commercialization.

  • Nanoenzalutamide leverages a novel polymer-embedded nanoparticle platform to overcome existing patent and formulation hurdles, enabling smaller, patient-centric tablets.

  • GLIORA, a long-acting intra-tumoral hydrogel for glioma, combines nanoformed APIs for synergistic local therapy, with a de-risked development plan and strong IP protection.

How does PeN technology differentiate Nanoenzalutamide?
How does Nanoform address biologics SC delivery gap?
What drives the 2030 GMP project transition target?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Nanoform Finland earnings date

Logotype for Nanoform Finland
Q4 202526 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Nanoform Finland earnings date

Logotype for Nanoform Finland
Q4 202526 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Nanoform provides nanotechnology and drug particle engineering services for the pharmaceutical industry. The company offers nanoparticle milling, a mechanical fragmentation process that reduces the particle size of APIs and enables the development of more bioavailable formulations. In addition, it provides physical characterization services for nanoparticles that comprises morphological analysis, including atomic force microscopy and scanning electron microscopy; elemental chemical analysis comprising inductively coupled plasma optical emission spectroscopy; and particle size distribution analysis comprising dynamic light scattering and laser diffraction, as well as supporting analytical equipment. The company was founded in 2008 and is headquartered in Helsinki, Finland.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage